Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-15 Purchase |
2022-03-16 08:35 am |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
4,100 | $3.6529 | $14,977 | 5,186 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-01 Option Award |
2023-11-03 4:49 pm |
N/A 2033-11-01 |
Matinas BioPharma Holdings Inc. | MTNB | Giordano Natasha Director |
437,244 | $0 | 437,244 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 9:36 pm |
N/A 2032-11-14 |
Matinas BioPharma Holdings Inc. | MTNB | Giordano Natasha Director |
142,657 | $0 | 142,657 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:13 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-11-01 Option Award |
2021-11-02 4:22 pm |
N/A 2031-11-01 |
Matinas BioPharma Holdings Inc. | MTNB | Giordano Natasha Director |
90,882 | $0 | 90,882 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 09:01 am |
N/A 2031-08-09 |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:39 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
350,000 | $0 | 350,000 (Direct) |
View |
Ownership |
2020-09-15 4:48 pm |
N/A 2030-09-10 |
Matinas BioPharma Holdings Inc. | MTNB | Giordano Natasha Director |
0 | $0 | 287,917 (Direct) |
View |